Janssen-Cilag companies operate in virtually all countries of the world and are active in a number of therapeutic areas such as pain, psychiatry, neurology, gastrointestinal and fungal diseases.
Over 6,000 Janssen-Cilag employees throughout Europe develop and market innovative, high-quality medicines
Janssen-Cilag is a product of the merger of two companies, Janssen Pharmaceutica and Cilag.
Please continue to learn more about Janssen-Cilag's history and our wide spectrum of products within different therapy areas.
